Leadership Overview
Lummus Technology has 4 executives leading key functions including strategy, finance, human resources, and legal.
Driven by innovation, Lummus Technology develops and licenses process technologies for the refining, petrochemical, and energy industries, enabling customers to convert raw materials into valuable fuels and chemicals.
Driven by innovation, Lummus Technology develops and licenses process technologies for the refining, petrochemical, and energy industries, enabling customers to convert raw materials into valuable fuels and chemicals.
Leadership Roles at Lummus Technology
Leon Bruyn - Chief Executive Officer
Leon Bruyn, the Chief Executive Officer at Lummus Technology, directs the company's overall strategy and global operations. Bruyn guides Lummus Technology's mission to develop and license cutting-edge process technologies for the refining, petrochemical, and energy sectors. This leadership involves steering the company's expansion into sustainable products and ensuring alignment with market demands for efficient feedstock conversion. Bruyn's focus remains on driving innovation and delivering proprietary technologies, catalysts, and equipment that empower clients worldwide. The Chief Executive Officer ensures Lummus Technology maintains its position as a global leader in energy technology and engineering solutions. Bruyn's executive oversight encompasses all facets of the business, from research and development to client services, solidifying the company's commitment to transforming raw materials into essential fuels and chemicals.
Erika Taurel - Chief Financial Officer
Erika Taurel, the Chief Financial Officer at Lummus Technology, manages the company's financial strategy and operations. Taurel oversees all fiscal activities, including financial planning, risk management, and capital allocation, ensuring the economic health of Lummus Technology's global endeavors. This role is critical in supporting the development and licensing of process technologies for the refining, petrochemical, and energy industries. The Chief Financial Officer works closely with other executives to drive Lummus Technology's mission of enabling customers to convert raw materials into fuels and chemicals. Taurel's financial acumen supports the company's investment in proprietary technologies, catalysts, and equipment, as well as its lifecycle services. Erika Taurel ensures Lummus Technology maintains robust financial performance while pursuing innovation and sustainable product development across its international operations.
Deepak Martin - Chief Human Resources Officer
Deepak Martin, the Chief Human Resources Officer at Lummus Technology, leads all human capital strategies and initiatives. Martin is responsible for cultivating a high-performance culture that supports Lummus Technology's global energy technology and engineering solutions. This involves attracting, developing, and retaining top talent essential for the company's innovation in process technologies for the refining, petrochemical, and energy industries. The Chief Human Resources Officer ensures that Lummus Technology's workforce is equipped to deliver proprietary technologies, catalysts, and equipment, and to provide comprehensive lifecycle services. Deepak Martin's leadership focuses on employee engagement, organizational development, and fostering an environment conducive to converting raw materials into valuable fuels and chemicals. Martin drives initiatives that align human resources with the company's strategic objectives and market impact.
Buck Foss - Chief Legal Officer
Buck Foss, the Chief Legal Officer at Lummus Technology, oversees all legal affairs and compliance for the global organization. Foss ensures that Lummus Technology operates within all regulatory frameworks, safeguarding the company's interests as it develops and licenses process technologies for the refining, petrochemical, and energy industries. This critical role supports the company's mission to provide proprietary technologies, catalysts, and equipment, and to offer lifecycle services that enable customers to convert raw materials into fuels and chemicals. The Chief Legal Officer manages intellectual property, contracts, and corporate governance, mitigating risks associated with international operations. Buck Foss's expertise is vital in navigating the complex legal landscape of the energy and chemical sectors, ensuring Lummus Technology's continued growth and adherence to ethical business practices worldwide.
Explore Leadership Teams in Business Services
PAREXEL International Corporation, a biopharmaceutical outsourcing services company, provides clinical research and logistics, medical communications, consulting, commercialization, and advanced technology products and services for pharmaceutical, biotechnology, and medical device industries worldwide. The company operates in three segments: Clinical Research Services (CRS), PAREXEL Consulting Services (PC), and PAREXEL Informatics (PI). The CRS segment offers clinical trials management, observational studies, patient/disease registries and post-marketing surveillance, data management, and biostatistical analysis, epidemiology and health economics/outcomes research, clinical supply and drug logistics, pharmacovigilance, commercialization, and clinical pharmacology, as well as related medical affairs, patient recruitment, and investigator site services. The PC segment provides technical expertise and advice in various areas, such as drug development, regulatory affairs, product pricing and reimbursement, commercialization, and strategic compliance; and market and product development, and targeted communications services to support product launch, as well as offers solutions to address client issues associated with product development, registration, and commercialization. The PI segment provides information technology solutions comprising ClinPhone randomization and trial supply management solutions, medical imaging services, IMPACT clinical trial management systems, LIQUENT InSight regulatory information management software and professional services, DataLabs electronic data capture systems, Web-based portals, systems integration services, electronic patient reported outcomes, and patient diary applications, as well as centralized assessment services for patient technology solutions. PAREXEL International Corporation was founded in 1983 and is headquartered in Waltham,...
Company Leadership AF

AS
FB
We are delighted to announce that our company name will be changing to Allucent. Purpose-built through the convergence of several leading providers, Allucent is a global provider of comprehensive drug development solutions across a variety of therapeutic areas with more than 30 years of experience and operations in over 60 countries. Our individualized partnership approach provides experience-driven insights and expertise to assist our clients in successfully navigating the complexities of delivering novel treatments to patients who need them.
Company Leadership AE
PS
HB

Founded in 1915, WEHI previously known as the Walter and Eliza Hall Institute of Medical Research, and as the Walter and Eliza Hall Institute, is Australia's oldest medical research institute. The company is headquartered in Parkville, Victoria, Australia.
Company Leadership AP
JD
SM
Founded in 2000 OraSure Technologies works globally to improve health and wellness by providing access to accurate, essential information. The company is headquartered in Bethlehem, Pennsylvania.
Company Leadership RW
CM
RM
KM